Invention Grant
![Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication](/docs/US/2018-09-04/US10065953B2/abs.jpg.600x600.jpg)
- Patent Title: Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication
-
Application No.: US15505955Application Date: 2015-08-25
-
Publication No.: US10065953B2Publication Date: 2018-09-04
- Inventor: Timothy P. Connolly , Kyle J. Eastman , B. Narasimhulu Naidu , Kevin Peese
- Applicant: ViiV Healthcare UK (No.5) Limited
- Applicant Address: GB Brentford, Middlesex
- Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
- Current Assignee: ViiV HEALTHCARE UK (NO.5) LIMITED
- Current Assignee Address: GB Brentford, Middlesex
- Agent Robert H. Brink; Edward R. Gimmi; William R. Majarian
- International Application: PCT/US2015/046648 WO 20150825
- International Announcement: WO2016/033009 WO 20160303
- Main IPC: C07D401/02
- IPC: C07D401/02 ; C07D401/10 ; A61K31/4353 ; A61K31/437 ; C07D471/04 ; A61P31/18 ; C07D519/00
![Imidazo[1,2-A]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication](/abs-image/US/2018/09/04/US10065953B2/abs.jpg.150x150.jpg)
Abstract:
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Public/Granted literature
- US20180222901A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION Public/Granted day:2018-08-09
Information query
